Evidence map›Paper›PMID 34357224›Full record

ReviewMicromachines2021

Diversity Models and Applications of 3D Breast Tumor-on-a-Chip.

Kena Song, Xiangyang Zu, Zhe Du, Zhigang Hu, Jingjing Wang, Jinghua Li

Abstract readReview
In one paragraph

Review in Micromachines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Design strategy primer for organ-on-chips.Biomaterials translational · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kena SongCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Xiangyang ZuCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Zhe DuCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Zhigang HuCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Jingjing WangCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Jinghua LiCollege of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.

Funding

key scientific research projects of colleges and universities 21A416005key specialized research and development breakthrough of He'nan province 192102310037, 212102310887Scientific Research Foundation for the Ph.D. (Henan University of Science and Technology) 13480030The National Natural Science Fund of China 31800836
6 · The paper itself

Abstract

Breast disease is one of the critical diseases that plague females, as is known, breast cancer has high mortality, despite significant pathophysiological progress during the past few years. Novel diagnostic and therapeutic approaches are needed to break the stalemate. An organ-on-chip approach is considered due to its ability to repeat the real conditions found in the body on microfluidic chips, offsetting the shortcomings of traditional 2D culture and animal tests. In recent years, the organ-on-chip approach has shown diversity, recreating the structure and functional units of the real organs/tissues. The applications were also developed rapidly from the laboratory to the industrialized market. This review focuses on breast tumor-on-a-chip approaches concerning the diversity models and applications. The models are summarized and categorized by typical biological reconstitution, considering the design and fabrication of the various breast models. The breast tumor-on-a-chip approach is a typical representative of organ chips, which are one of the precedents in the market. The applications are roughly divided into two categories: fundamental mechanism research and biological medicine. Finally, we discuss the prospect and deficiencies of the emerging technology. It has excellent prospects in all of the application fields, however there exist some deficiencies for promotion, such as the stability of the structure and function, and uniformity for quantity production.

Indexed as

applicationsbreast modelsbreast tumor-on-a-chip

Identifiers

PMID34357224
PMCPMC8306159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.